Table 3 Multivariable logistic regression analysis of potential risk factors for mortality in patients with dementia.

From: Impact of the COVID-19 pandemic on mortality and loss to follow-up among patients with dementia receiving anti-dementia medications

 

Unadjusted OR

Adjusted OR

p-value

Diagnosed year, 2019 compared to 2018

1.03 (0.99–1.06)

0.99 (0.96–1.02)

0.5190

Sex, male

1.75 (1.70–1.81)

2.10 (2.03–2.17)

 < 0.001

Age, group

 < 50

0.17 (0.12–0.25)

0.09 (0.06–0.13)

 < 0.001

 50–59

0.27 (0.24–0.31)

0.18 (0.16–0.21)

 < 0.001

 60–69

0.35 (0.33–0.37)

0.27 (0.26–0.29)

 < 0.001

 70–79

0.48 (0.46–0.49)

0.45 (0.43–0.46)

 < 0.001

 ≥ 80

1 [Ref]

1 [Ref]

 

CCI

 0

1.07 (1.03–1.11)

0.89 (0.78–1.01)

0.0711

 1–2

0.99 (0.94–1.04)

0.83 (0.80–0.87)

 < 0.001

 ≥ 3

1 [Ref]

1 [Ref]

 

Residence, metropolitan

0.95 (0.92–0.98)

1.04 (1.00–1.07)

0.0283

Medical department, Neurology, or Psychiatry

0.47 (0.46–0.49)

0.47 (0.46–0.49)

 < 0.001

Income level

 < 40%

1.07 (1.03–1.11)

1.12 (1.08–1.16)

 < 0.001

 40–60%

0.99 (0.94–1.04)

1.05 (0.99–1.10)

0.0927

 ≥ 60%

1 [Ref]

1 [Ref]

 
  1. Data are presented as odds ratios (95% confidence interval). Logistic regression analysis was used, p for multivariate models. Adjusted for age group, sex, CCI score, residence, comorbidity, classification of medical institutions, medical department, and income level. CCI Charlson-Romano comorbidity index.
Back to article page